v3.26.1
SEGMENT INFORMATION- Schedule of Disaggregation of Total Net Product Revenues by Geographic Region (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Disaggregation of Revenue [Line Items]        
Total revenues $ 989,708 $ 825,410 $ 1,755,916 $ 1,570,555
ALDURAZYME        
Disaggregation of Revenue [Line Items]        
Total revenues 43,539 56,437 80,281 105,414
Net product revenues        
Disaggregation of Revenue [Line Items]        
Total revenues 984,393 812,982 1,744,471 1,547,626
Marketed by Company | Products excluding ALDURAZYME        
Disaggregation of Revenue [Line Items]        
Total revenues 940,854 756,545 1,664,190 1,442,212
Marketed by Company | Products excluding ALDURAZYME | United States        
Disaggregation of Revenue [Line Items]        
Total revenues 371,074 272,554 614,018 514,248
Marketed by Company | Products excluding ALDURAZYME | Europe        
Disaggregation of Revenue [Line Items]        
Total revenues 297,498 243,138 516,334 472,716
Marketed by Company | Products excluding ALDURAZYME | Latin America        
Disaggregation of Revenue [Line Items]        
Total revenues 103,917 98,118 212,081 186,400
Marketed by Company | Products excluding ALDURAZYME | Rest of world        
Disaggregation of Revenue [Line Items]        
Total revenues 168,365 142,735 321,757 268,848
Marketed by Sanofi | ALDURAZYME        
Disaggregation of Revenue [Line Items]        
Total revenues $ 43,539 $ 56,437 $ 80,281 $ 105,414